Clevidipine是短效二氢吡啶钙离子通道拮抗剂,IC50为7.1 nM。
Clevidipine Butyrate is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ahmed S Awad,et al. Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. Vasc Health Risk Manag. 2010; 6: 457–464. Published online 2010 Aug 9.
分子式 C21H23Cl2NO6 |
分子量 456.32 |
CAS号 167221-71-8 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 90 mg/mL |
Water <1 mg/mL |
Ethanol 5 mg/mL |
体内溶解度
NCT00978822 | Subarachnoid Hemorrhage|Hypertension | Drug: Clevidipine butyrate injectable emulsion | Henry Ford Health System|The Medicines Company | Phase 2 | 2009-09-01 | 2009-09-17 |
NCT01526876 | Hypertension | Drug: clevidipine butyrate | Columbia University|The Medicines Company | Phase 4 | 2011-11-01 | 2013-02-26 |
NCT01042574 | Hypertension|Intracranial Hemorrhage|Subarachnoid Hemorrhage | Drug: Clevidipine butyrate | Methodist Healthcare|The Medicines Company | Phase 4 | 2010-05-01 | 2012-06-18 |
NCT00952081 | Hypertension|Brain Tumor|Epilepsy | Drug: Clevidipine | New York University School of Medicine|The Medicines Company | Phase 4 | 2009-07-01 | 2015-01-26 |
NCT01938547 | Pediatric Perioperative Blood Pressure Management | Drug: clevidipine | The Medicines Company | Phase 4 | 2014-03-01 | 2014-08-21 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们